Comparison of the efficacies of first-generation epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in patients with advanced non-small-cell lung cancer harboring EGFR mutations

BACKGROUND: Compared with standard chemotherapy, epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are more effective in patients with advanced non-small-cell lung cancer (NSCLC) harboring EGFR mutations. However, data comparing the efficacies of different EGFR−TKIs, especially...

Descripción completa

Detalles Bibliográficos
Autores principales: Aiko, Naoto, Shimokawa, Tsuneo, Miyazaki, Kazuhito, Misumi, Yuki, Agemi, Yoko, Ishii, Mari, Nakamura, Yukiko, Yamanaka, Takeharu, Okamoto, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196437/
https://www.ncbi.nlm.nih.gov/pubmed/30348116
http://dx.doi.org/10.1186/s12885-018-4911-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196437/
https://www.ncbi.nlm.nih.gov/pubmed/30348116
http://dx.doi.org/10.1186/s12885-018-4911-7

Ejemplares similares